Repligen Corporation (RGEN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
215.47+3.22 (+1.52%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 212.25 |
| Open | 213.75 |
| Bid | 215.00 x 900 |
| Ask | 217.55 x 1100 |
| Day's Range | 212.40 - 217.78 |
| 52 Week Range | 78.41 - 221.38 |
| Volume | 417,738 |
| Avg. Volume | 424,174 |
| Market Cap | 11.79B |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | 261.18 |
| EPS (TTM) | 0.82 |
| Earnings Date | Feb 18, 2021 - Feb 22, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 211.50 |
- Investor's Business Daily
Why This IBD Stock Of The Day Is On A Run As Covid Vaccine Demand Surges
Repligen is the IBD Stock Of The Day. Shares of RGEN stock are lingering in a chase zone after busting out of a cup base on Thursday. The company is a leader in bioprocessing.
- Investor's Business Daily Video
Repligen In Buy Zone
Repligen is in a buy zone following two weeks of strong gains. RS line picking up.
- Investor's Business Daily
Dow Jones Fades As Market Watches Biden's $2 Trillion Stimulus Plan; Jobless Claims Disappoint
The Dow Jones traded modestly higher in today's stock market as the blue chip index and the Nasdaq composite faded from earlier gains.
© 2021 Verizon Media. All rights reserved.
